Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Overview: 2025-2030

Base Year: 2024

Historical Years:  2020-23

Forecast Years: 2025-2030

The Global Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30. The Global Colorectal Cancer (CRC) Diagnostics and Treatments Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.

Markntel Advisor’s Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Colorectal Cancer (CRC) Diagnostics and Treatments Market drivers, barriers, Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Trends, and Key Players in Global Colorectal Cancer (CRC) Diagnostics and Treatments Market.

Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/colorectal-cancer-crc-market.html

Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Dynamics: 2025-2030

Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Driver:

High Ubiquity of Colorectal Cancer Driving Demand – Globally, colorectal cancer is a major health concern. 930,000 people died and 10. 9 million new cases were reported worldwide in 2020. The number of cases is expected to increase to 32. 2 million by 2040, with 12. 6 million expected deaths. The disease is most common in countries with high or extremely high HDI. With 10% of cases worldwide, it is the second most common cause of cancer-related deaths and the third most common type of cancer overall. Different geographic prevalence rates indicate that colorectal cancer (CRC) is most common in Australia, New Zealand, and Europe, while it is less common in some parts of Africa and Southern Asia.

These geographic disparities underscore the necessity for regional strategies in CRC management. In light of the increasing incidence of CRC, novel diagnostic technologies are being created. A recent innovation involves a small robot that can travel through the digestive tract and conduct 3D scans to facilitate improved early detection and treatment. The high incidence will drive the market growth throughout the forecast period and beyond.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/colorectal-cancer-crc-market.html

Global Colorectal Cancer (CRC) Diagnostics and Treatments Market (2025-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Diagnosis

-Blood & Stool Tests

-Imaging

-Biopsy

-Flexible Sigmoidoscopy

-Colonoscopy

By Treatment

-Chemotherapy

-Alkylating Agents

-Antimetabolites

-Fluorouracil

-Capecitabine

-Others

-Immunotherapy

-Monoclonal Antibodies

-Bevacizumab

-Cetuximab

-Panitumumab

-Biologic Response Modifiers

-Colony-Stimulating Factors

-Tumor Vaccines

-Surgery

-Targeted Therapy

-Others (Radiofrequency Ablation (RFA), etc.)

By End-User

-Hospitals

-Specialty Clinics

-Others (Ambulatory Surgery Centers, etc.)

By Region

-North America

-South America

-Europe

-Middle East & Africa

-Asia-Pacific.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market:

Abbott Laboratories, Amgen Inc., Bayer AG, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India